Posts by: David Melamed, PhD

David Melamed, PhD

David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.

November 13, 2020November 13, 2020

Bronchiectasis Worsens Lung Function, Quality of Life in Severe Asthma, Study Finds

News

People with severe asthma have worse lung function, lower quality of life, and more exacerbations if they also have bronchiectasis, an Italian study found. The study, “Clinical features associated with ... Read more

October 16, 2020October 16, 2020

Sit-to-stand Test Ably Captures Exercise Capacity of Children, Study Finds

News

The 30-second sit-to-stand test is a valid alternative to the traditional six-minute walk test in measuring the exercise capacity of children with bronchiectasis, a study found. The study, “Sit-to-stand test ... Read more

July 6, 2020July 6, 2020

Greater Difficulty in Breathing Linked to More Severe Bronchiectasis, Study Finds

News

Greater severity of dyspnea, or labored breathing, is associated with higher functional impairment in people with bronchiectasis, a study has found. Results also indicated that using multiple assessments is best ... Read more

June 19, 2020June 19, 2020

Renovion Raises $8.1M to Advance ARINA-1 Nebulizer Therapy

News

Renovion has secured $8.1 million in funding for the clinical development of ARINA-1 (ascorbic acid), an experimental nebulizer therapy to clear mucus and reduce inflammation in people with non-cystic fibrosis bronchiectasis ... Read more